Plasma Proteome Profiling Identified thrombospondin-1 and lactoferrin as Biomarkers of Relapsed Multiple Myeloma

Name: Plasma Proteome Profiling Identified thrombospondin-1 and lactoferrin as Biomarkers of Relapsed Multiple Myeloma
Creator: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
License: 暂无描述

integrated proteome resources2026-02-07 收录

下载链接：

https://www.iprox.cn/page/project.html?id=IPX0007180000

下载链接

链接失效反馈

官方服务：

资源简介：

Plasma Proteome Profiling Identified thrombospondin-1 and lactoferrin as Biomarkers of Relapsed Multiple Myeloma

提供机构：

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

创建时间：

2023-09-22

癌症生物标志物的临床意义数据

条件：适用于了解癌症诊疗过程中生物标志物检测的临床意义。具体可用于：1）生物标志物检测结果的医学解读；2）生物标志物检测开发时，辅助制定检测的靶点；3）癌症诊疗过程中，指导需要接受的生物标志物检测。范围：癌症相关的生物标志物检测对象：生物标志物检测供应商、临床医生、癌症患者或高风险人群、科研学术工作者解决的主要问题：癌症生物标志物的数据库通过收集和整理获批药物、文献等不同来源的证据，可有效的

浙江省数据知识产权登记平台2024-05-07 更新200

Supplementary Material for: Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases

Advanced melanoma patients with liver metastases show a limited response to immunotherapy by the induction of regulatory T cells and depletion of effector cells, which leads to a poor prognosis. Tumor

DataCite Commons2022-12-28 更新130

A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers

Beta-actin (ACTB), a highly conserved cytoskeleton structural protein, has been regarded as a common housekeep gene and used as a reference gene for years. However, accumulating evidence indicates tha

NIAID Data Ecosystem130

Abatacept Restores Dysregulated Transcriptomic and Proteomic Profiling in LRBA Deficiency

The source data accompanying the manuscript includes the raw data files from both the NanoString gene expression analysis and the SomaLogic plasma proteomics analysis. These datasets serve as the foun

DataCite Commons2025-06-01 更新170

NOTCH1 mutation predicts better clinical survival benefit of tislelizumab in second-line esophageal squamous cell carcinoma: a RATIONALE-302 study biomarker analysis

In a mouse model of esophageal cancer, we conducted single-cell sequencing analysis of tumor tissues from mice with endogenous NOTCH1 knockout and control groups, finding that NOTCH1 mutation promotes

DataCite Commons2025-05-01 更新130